Using AI based predictive genomics for drug target discovery
Outsee is a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery. OutSee’s proprietary Nomaly technology predicts disease and phenotype ab initio directly from a single genome. Unlike other methods commonly used for target discovery, the AI-powered engine uses hypothesis-free, predictive modelling to draw conclusions from the fundamental molecular and cellular biology of the genome, rather than by pattern-matching known genetic associations.
Prof. Julian Gough
Prof. Chang Lu
Genetics & Platform Technologies